DLPIC
SYNH

Davide Leone & Partners Investment Company’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,947
Closed -$2.8M – 114
2021
Q1 		$2.8M Buy
36,947
+11,062
+43% +$834K 0.35% 25
2020
Q4 		$1.76M Buy
+25,885
New +$1.61M 0.18% 44

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Davide Leone & Partners Investment Company's SYNH Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 36,947 shares — an estimated $2.8M sold.

Davide Leone & Partners Investment Company first reported a position in SYNH in Q4 2020 and held it in 2 quarters. The position peaked at $2.8M in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 36,947 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $2.8M.
  • Davide Leone & Partners Investment Company first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 2 quarters.
  • Davide Leone & Partners Investment Company's Syneos Health, Inc. Class A Common Stock position peaked at $2.8M in Q1 2021.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.